Hallett M, Burden S, Stewart D, Mahony J, Farrell P
ResCare Ltd, North Ryde, New South Wales, Australia.
ASAIO J. 1995 Jul-Sep;41(3):M435-41. doi: 10.1097/00002480-199507000-00047.
Fifteen unselected end-stage renal disease patients (nine hemodialysis [HD] and six continuous ambulatory peritoneal dialysis [CAPD]) were randomly selected from four Sydney metropolitan dialysis centers for sleep assessment by full polysomnography. Four of six CAPD patients and eight of nine HD patients were found to have clinically significant obstructive sleep apnea. An additional 21 unselected patients (10 CAPD and 11 HD patients) were assessed using overnight home monitoring of nasal airflow and arterial oxygen saturation. Of these, 8 of the 11 HD and 7 of the 10 CAPD patients were found to have obstructive sleep apnea. These data confirm the high incidence of obstructive sleep apnea in the end-stage renal disease population at large. Screening for obstructive sleep apnea should become a routine part of the management of these patients.
从悉尼四个大都市透析中心随机选取15例未经挑选的终末期肾病患者（9例血液透析[HD]患者和6例持续性非卧床腹膜透析[CAPD]患者），通过全夜多导睡眠图进行睡眠评估。6例CAPD患者中有4例，9例HD患者中有8例被发现患有具有临床意义的阻塞性睡眠呼吸暂停。另外21例未经挑选的患者（10例CAPD患者和11例HD患者）通过夜间家庭监测鼻气流和动脉血氧饱和度进行评估。其中，11例HD患者中有8例，10例CAPD患者中有7例被发现患有阻塞性睡眠呼吸暂停。这些数据证实了终末期肾病患者总体中阻塞性睡眠呼吸暂停的高发病率。阻塞性睡眠呼吸暂停的筛查应成为这些患者管理的常规组成部分。
